Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07220005 · ClinicalTrials.gov registry record · NA

Low Intensity Focused Ultrasound Stimulation in Stroke Patients - Parameter Optimization

A NA study of Stroke and Arm Weakness as a Consequence of Stroke, sponsored by Duke University.

Recruiting
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT07220005: Recruiting NA study of Stroke and Arm Weakness as a Consequence of Stroke, sponsored by Duke University.

NCT07220005 is a NA study of Stroke and Arm Weakness as a Consequence of Stroke that is actively recruiting participants, run by Duke University. The registered enrollment target is 24 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07220005, a NA study of Stroke and Arm Weakness as a Consequence of Stroke, is actively recruiting participants, sponsored by Duke University.

RECRUITING
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

The goal of this research study is to optimize the parameter of Low-Intensity Focused Ultrasound Stimulation (LIFUS) that is most effective in changing cortical excitability and motor learning skills in patients who suffered a stroke. The researchers hope to answer two questions. * with increasing power, would LIFUS be more effective? * with the same power, what LIFUS timing is the best For Aim 1, the study will compare 8, 4 W/cm\^2 to a zero(sham) stimulation to see if higher power is the better. For Aim 2, the study will compare 500 vs 1000 vs 2000 Hz "timing" to see which one is better.

Primary Outcome

Motor sequence learning (MSL) involves predictive processing that results in the anticipation of each component of a sequence of actions. MSL will produce response times and the MSL measure will be the number of responders (i.e., those with ≥20% reduction in the response time).

Interventions

  • DEVICE Low intensity focused ultrasound stimulation

Study Locations (1)

North Carolina

  • Duke University Hospital - Durham

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2025-12-10
Est. Completion 2026-06-30
Phase NA
Duke University

1,725 total trials

What NCT07220005 shows while recruiting

NCT07220005 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).

The record links to 5 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Low intensity focused ultrasound stimulation is the first listed.

NCT07220005 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT07220005 about?

NCT07220005 is a clinical study titled "Low Intensity Focused Ultrasound Stimulation in Stroke Patients - Parameter Optimization". The goal of this research study is to optimize the parameter of Low-Intensity Focused Ultrasound Stimulation (LIFUS) that is most effective in changing cortical excitability and motor learning skills in patients who suffered a stroke. The researchers hope to answer two questions. * with increasing ...

What is the current status of trial NCT07220005?

This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2025-12-10. Estimated completion is 2026-06-30.

What conditions does trial NCT07220005 study?

This clinical trial studies the following conditions: Stroke, Arm Weakness as a Consequence of Stroke, Upper Extremity Impairments, Upper Extremity Weakness, Upper Extremity Hemiparesis.

What interventions are being tested in trial NCT07220005?

The interventions under investigation include: Low intensity focused ultrasound stimulation (DEVICE).

Who is sponsoring clinical trial NCT07220005?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07220005 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07220005's enrollment target sits among peer trials

24 336th of 454 higher than 109 of 454 other Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07220005, the US trial registry maintained by the National Library of Medicine. NCT07220005 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.